Citizens & Northern Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
41,436
+1,447
| +4% | +$55.6K | 0.43% | 51 |
|
|
2025
Q1 | $1.55M | Sell |
39,989
-1,154
| -3% | -$44.7K | 0.44% | 51 |
|
|
2024
Q4 | $1.39M | Buy |
41,143
+1,207
| +3% | +$40.8K | 0.38% | 55 |
|
|
2024
Q3 | $1.63M | Buy |
39,936
+3,151
| +9% | +$129K | 0.49% | 47 |
|
|
2024
Q2 | $1.42M | Sell |
36,785
-1,758
| -5% | -$67.7K | 0.44% | 53 |
|
|
2024
Q1 | $1.65M | Sell |
38,543
-1,042
| -3% | -$44.7K | 0.56% | 42 |
|
|
2023
Q4 | $1.47M | Sell |
39,585
-1,426
| -3% | -$52.8K | 0.52% | 47 |
|
|
2023
Q3 | $1.49M | Sell |
41,011
-1,430
| -3% | -$51.8K | 0.6% | 43 |
|
|
2023
Q2 | $1.51M | Buy |
42,441
+1,786
| +4% | +$63.7K | 0.57% | 45 |
|
|
2023
Q1 | $1.45M | Buy |
40,655
+388
| +1% | +$13.8K | 0.56% | 48 |
|
|
2022
Q4 | $1.41M | Buy |
+40,267
| New | +$1.41M | 0.58% | 49 |
|